Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Oncology Institute Inc
NASDAQ:STLN

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:STLN
Watchlist
Price: 6.52 USD 5.67% Market Closed
Market Cap: $651.9m
Write Note Create Alert Ask AI

Wall St Price Targets

STLN Price Targets Summary
Oncology Institute Inc

Wall Street analysts forecast STLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STLN is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

STLN Lowest Forecast
Wall Street Target
$7.07
8% Upside
STLN Average Forecast
Wall Street Target
$9.18
41% Upside
STLN Highest Forecast
Wall Street Target
$11.55
77% Upside
Lowest Forecast
Price Target
7.07 USD
8% Upside
Average Forecast
Price Target
9.18 USD
41% Upside
Highest Forecast
Price Target
11.55 USD
77% Upside
Oncology Institute Inc Competitors:
Price Targets

Revenue
Forecast

22% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
22% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 30%.

What are analyst estimates?

Gross Profit
Forecast

17% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
17% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 6 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 37%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue STLN Research

Summary
STLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
STLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
STLN stock valuation using valuation multiples.
Wall St Estimates
STLN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
STLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is STLN's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for STLN is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

What is the Revenue forecast for Oncology Institute Inc?
Projected CAGR
30%

Over the last 6 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 30%.

What is the Gross Profit forecast for Oncology Institute Inc?
Projected CAGR
37%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 37%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.